http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110787166-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
filingDate 2019-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110787166-B
titleOfInvention Small molecule compound C28H26Cl2N8Application in E.coli meningitis
abstract The invention discloses a small molecule compound C 28 H 26 Cl 2 N 8 The compound or an isomer, a solvate or a precursor thereof, or pharmaceutically acceptable salts thereof can be combined with hot spot amino acid residues of interaction of a brain vascular endothelial receptor protein Caspr1 in a bacterial meningitis virulence factor IbeA protein in a targeted competitive manner so as to block the combination of the two, thereby achieving the purpose of preventing the escherichia coli from passing through a blood brain barrier or blocking the meningitis escherichia coli from invading neurons. The invention provides a novel targeted medicine for preventing and treating the bacterial meningitis of the newborn by adopting a novel targeted treatment method from the viewpoints of intervening the interaction of a ligand (IbeA) -receptor (Caspr1) of a bacterium-host and blocking pathogenic bacteria.
priorityDate 2019-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9936410-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448365594
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60374
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID480124
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8506
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431847471
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135900090
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373673
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16905
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID195815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39118
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID457385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23662274
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID53321
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38723
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396222
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID34068
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4000
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396224

Total number of triples: 40.